COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 646: Articles 6451-6460  | Next

Evolution of antibody immunity following Omicron BA.1 breakthrough infection
Kaku, C. I., Starr, T. N., Zhou, P., Dugan, H. L., Khalife, P., Song, G., Champney, E. R., Mielcarz, D. W., Geoghegan, J. C., Burton, D. R., Andrabi, R., Bloom, J. D., Walker, L. M.
10.1101/2022.09.21.508922 — Posted: 2022-09-22
Dose of approved COVID-19 vaccines is based on weak evidence: a review of early-phase, dose-finding trials
Dunn, D., Gilson, R., McCormack, S., McCoy, L.
10.1101/2022.09.20.22276701 — Posted: 2022-09-22
Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2
Rudraraju, R., Gartner, M. J., Neil, J. A., Stout, E. S., Chen, J., Needham, E. J., See, M., Mackenzie-Kludas, C., Yang, L. Y., Wang, M., Pointer, H., Karavendzas, K., Abu-Bonsrah, D., Drew, D., Sun, Y. B. Y., Tan, J. P., Sun, G., Salavaty, A., Charitakis, N., Nim, H. T., Currie, P. D., Tham, W.-H., Porrello, E., Polo, J., Humphrey, S. J., Ramialison, M., Elliott, D. A., Subbarao, K.
10.1101/2022.09.20.508614 — Posted: 2022-09-21
Exposure to BA.4/BA.5 Spike glycoprotein drives pan-Omicron neutralization in vaccine-experienced humans and mice
Muik, A., Lui, B. G., Bacher, M., Wallisch, A.-K., Toker, A., Couto, C. I. C., Gueler, A., Mampilli, V., Schmitt, G. J., Mottl, J., Ziegenhals, T., Fesser, S., Reinholz, J., Wernig, F., Schraut, K.-G., Hefesha, H., Cai, H., Yang, Q., Walzer, K. C., Grosser, J., Strauss, S., Finlayson, A., Krueger, K., Ozhelvaci, O., Grikscheit, K., Kohmer, N., Ciesek, S., Swanson, K. A., Vogel, A. B., Tuereci, O., Sahin, U.
10.1101/2022.09.21.508818 — Posted: 2022-09-21
Association of polymorphisms of IL-6 pathway genes (IL6, IL6R and IL6ST) with COVID-19 severity in an Amazonian population.
Rodrigues, F. B. B., Sahoo, M.
10.1101/2022.09.21.508870 — Posted: 2022-09-21
PepGM: A probabilistic graphical model for taxonomic inference of viral proteome samples with associated confidence scores
Holstein, T., Kistner, F., Martens, L., Muth, T.
10.1101/2022.09.21.508832 — Posted: 2022-09-21
Prediction of RNA secondary structures in SARS-CoV-2 and comparison with contemporary predictions
Ziesel, A., Jabbari, H.
10.1101/2022.09.20.508790 — Posted: 2022-09-21
Prevalence of SARS-CoV-2 Antibodies after the Omicron Surge, Kingston, Jamaica, 2022
Anzinger, J. J., Cameron-McDermott, S. M., Phillips, Y. Z., Mendoza, L., Anderson, M., Cloherty, G., Strachan-Johnson, S., Lindo, J. F., Figueroaa, J. P.
10.1101/2022.09.20.22280173 — Posted: 2022-09-21
Comprehensive analysis of immune responses in CLL patients after heterologous COVID-19 vaccination
Lee, H. K., Hoechstetter, M. A., Buchner, M., Pham, T. T., Huh, J. W., Muller, K., Zange, S., von Buttlar, H., Girl, P., Wolfel, R., Brandmeier, L., Pfeuffer, L., Furth, P. A., Wendtner, C.- M., Hennighausen, L.
10.1101/2022.09.21.22280205 — Posted: 2022-09-21
Safety, Immunogenicity and Efficacy of NVX-CoV2373 in Adolescents in PREVENT-19: A Randomized, Phase 3 Trial
Anez, G., Dunkle, L. M., Gay, C. L., Kotloff, K. L., Adelglass, J. M., Essink, B., Campbell, J. D., Cloney-Clark, S., Zhu, M., Plested, J. S., Roychoudhury, P., Greninger, A. L., Patel, N., McGarry, A., Woo, W., Cho, I., Glenn, G. M., Dubovsky, F.
10.1101/2022.09.20.22279903 — Posted: 2022-09-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).